Gitnux/Report 2026

Plasma Donation Industry Statistics

The global plasma fractionation market is estimated at $42.15B in 2026, explore the figures behind growth, companies, and trends in plasma donation.
30Statistics
31Sources
7Sections
1Visuals
17mRead
November 20, 2026Updated
Plasma Donation Industry Statistics
Aisha OkonkwoWritten by Aisha Okonkwo·Edited by Min-ji Park·Fact-checked by Astrid Bergmann
Published ·Updated
How this report is researched
01Editorial Scope

An editor sets the topic, the inclusion criteria, and the evaluation framework before research starts.

02Source Research

AI search agents locate sources and extract each figure together with the document it came from.

Read our full methodology →

Search agents attach provenance to every extracted figure.

Next review: within 28 days

01 Industry overview

The plasma donation industry at a glance

The plasma donation industry is anchored by the United States, where an estimated 62.5 million liters of plasma were collected in 2025 across 1,247 centers, supplying a large share of global plasma-derived medicine production.

$42.15B[18]
Global market estimate, 2026
8.4%[18]
Forecast CAGR, 2026–2031
62.5M liters[19]
U.S. plasma collected, 2025
1,247[19]
U.S. plasma centers, 2025
Market size
The global plasma fractionation market was estimated at $42.15 billion in 2026, with plasma collection serving as the essential upstream input for immunoglobulins, albumin and coagulation products. A separate 2024 estimate placed global plasma-fractionation revenue at $37.31 billion, indicating that published estimates vary by market definition and methodology.[18][20]
Forecast & CAGR
Mordor Intelligence forecasts the plasma fractionation market to grow from $38.88 billion in 2025 to $63.06 billion in 2031, representing an 8.4% CAGR from 2026 to 2031. Growth is linked to rising demand for immunoglobulin and other plasma-derived therapies.[18]
Market share & regions
North America accounted for 56.2% of global plasma-fractionation revenue in 2024, compared with 21.3% for Europe and 19.0% for Asia-Pacific. The United States is the dominant collection hub: an estimated 62.5 million liters were collected there in 2025, and the country supplied approximately 68% of the world’s plasma for plasma-derived medicines.[20][19]
Segmentation
The industry is segmented by collection type—source plasma collected by plasmapheresis and recovered plasma obtained from whole-blood donations—and by downstream product, including immunoglobulins, albumin and coagulation factors. CSL reports that 1,200 plasma donations are needed to treat one person with severe haemophilia for one year, illustrating the particularly plasma-intensive nature of some therapies.[6]
Key players & concentration
Collection and fractionation are concentrated among large vertically integrated operators, including CSL, Grifols, Takeda and Octapharma. At year-end 2025, Grifols operated 310 U.S. plasma centers, 97 in Europe and 33 elsewhere, while CSL reported nearly 330 centers across the United States, Germany and Hungary.[8]
Pricing
U.S. donor compensation commonly ranges from $30 to $70 per donation, although introductory promotions and local schedules can be higher. CSL Plasma advertises up to $100 for a first donation and up to $800 during a new donor’s first month, with amounts varying by location.[21][2]
Trends, drivers & challenges
Demand is being driven by expanding use of immunoglobulin and other plasma-derived therapies, while operators are investing in faster and more individualized collection technology. CSL introduced more than 200 Rika plasmapheresis machines in 2025, reducing average donation time from 90–120 minutes to 60–80 minutes; challenges include donor retention, regulatory compliance, center productivity and dependence on U.S. collections.[2][19]
Consumer behavior & competition
The U.S. market relies heavily on repeat, compensated donors: CSL states that the average U.S. plasma donor can donate up to 21 times per year, while federal rules generally allow plasma donation no more than twice in seven days. Donor competition is based on compensation, convenience, waiting time, center availability and the perceived safety of the collection process.[11]
M&A
Consolidation continued in 2025: Grifols acquired eight U.S. plasma-collection centers from ImmunoTek for approximately $79 million on January 2, 2025, and acquired six additional centers for approximately $62 million effective February 3, 2025. These transactions expanded Grifols’ collection network and supply base.[22][23]
Regulation
U.S. plasma establishments operate under FDA requirements covering donor eligibility, medical history and examination, collection procedures, testing and quarantine. In October 2026, FDA finalized guidance addressing donation suitability, donor eligibility and quarantine-hold requirements for Source Plasma under 21 CFR parts 630 and 640.[11][24]
Latest news
In October 2026, CSL announced an expanded relationship with Haemonetics and said it expects to complete deployment of Haemonetics’ latest-generation plasmapheresis platform across its U.S. collection centers by the end of 2027. In April 2026, Grifols announced the closure of 29 U.S. donation centers as part of a network-productivity and utilization program.[8]

02 Ranking

Top 10 Companies in the Plasma Donation Industry

The leading companies in the plasma donation industry, ranked on market impact, performance, momentum, innovation and brand popularity.

Updated November 20, 2026 · Next review December 20, 2026

Verdict

Grifols stands out for operating a large worldwide plasma collection network because it operates over 390 plasma donation centers through BioMat, while Eurofins Transplant Genomics focuses on plasma donation testing services since it provides infectious disease screening.

Ranked by Overall score · How we score ↓

Editor's top 3 picks

Where to start, by need.

  1. #1 Overall · Leader in plasma collection

    Grifols

    ES

    Ranked #1 · 9.1 · Plasma collection

    Why we picked it: It operates over 390 plasma donation centers worldwide through BioMat and other subsidiaries.

  2. Leader in plasma testing

    Eurofins Transplant Genomics

    LU

    Ranked #2 · 9.0 · Plasma testing

    Why we picked it: It provides plasma donation testing services including infectious disease screening for plasma collection.

  3. Leader in plasma fractionation

    CSL

    AU

    Ranked #4 · 8.9 · Plasma fractionation

    Why we picked it: It operates CSL Plasma, a large plasma collection network with 300+ centers globally.

Pick 1 is the #1 company overall. Picks 2 and 3 are the highest-ranked companies in the top 5 that add a new segment.

Full ranking

Sort by
Top 10 companies in the plasma donation industry, 2026 – Gitnux ranking
#CompanyOverall ↓Company snapshot
1

Grifols

Plasma collection · ES

9.1
2

Eurofins Transplant Genomics

Plasma testing · LU

9.0
3

CSL Plasma

Plasma collection · US

9.0
4

CSL

Plasma fractionation · AU

8.9
5

Octapharma

Plasma collection · CH

8.8
6

ADMA Biologics

Plasma collection and fractionation, US · US

8.7
7

Takeda

BioLife Plasma Services centers and plasma-derived therapies · JP

8.7
8

GC Biopharma

Plasma-derived therapies, South Korea · KR

8.5
9

B Positive Plasma

Compensated plasma collection, United States · US

8.2
10

Biotest

Plasma protein products manufacturer, Germany · DE

7.5

How we score

  • Impact (30%): scale and weight in the market (revenue, market share, employees, market position).
  • Performance (20%): recent revenue growth and operating margin; an analyst assessment where a company does not publish them.
  • Momentum (20%): growth trajectory and future potential.
  • Innovation (15%): R&D intensity and how technologically advanced the company is.

Popularity (brand search demand, 15%) counts toward Overall but is not published as a column. Overall leaves out what is not known.

Scale Scores are shown on a 7–10 scale with one decimal; bars start at 7.0.

Cadence Recalculated when new figures are published; next review December 20, 2026.

Independence. Rankings are editorially independent. Scores, ranks, picks and the verdict follow the method above; no company can pay to change them.

Cite this ranking

APA

Aisha Okonkwo. (2026, February 13). Top 10 companies in the plasma donation industry. In Plasma Donation Industry Statistics. Gitnux. https://gitnux.org/plasma-donation-industry-statistics/#top-companies

report visual · Comparison

Revenue of the largest plasma donation companies

CSL leads with $14.8B in annual revenue (group level, converted to USD).

CSL$14.8B
Eurofins Transplant Genomics$7.5B
Grifols$7.1B
Octapharma$3.5B
ADMA Biologics$418M
source-verifiedcsl.com · eurofins.com · grifols.com · octapharma.com · admabiologics.com2024

04 Statistics

Technology & AI

We see near-universal automation in source-plasma collection facilities, and CSL’s Rika rollouts cut average donation time from 90–120 minutes to 60–80 minutes in 2025.

AI and automation in the plasma donation industry

  • Nearly 100% of source-plasma collections worldwide used automated collection technology at dedicated facilities in fiscal 2026, according to Haemonetics.[1]
  • More than 200 Rika plasmapheresis machines reduced average CSL Plasma donation time from 90–120 minutes to 60–80 minutes in 2025, a measured automation-related change in U.S., German and Hungarian plasma centers.[2]
  • 100% of CSL Plasma centers in the United States had the Rika automated plasma-collection system by September 2025, completing a nationwide rollout.[3]

05 Statistics

Market Intelligence

U.S. supply dominates the upstream input, with 62.5 million liters collected in 2025 across 1,247 commercial centers, alongside $4.7 billion in U.S. donor compensation that year.

Market size and service revenue in the plasma donation industry

  • 62.5 million liters of plasma were collected in the United States in 2025; the estimate covers commercial source-plasma collection for medicines, not recovered plasma from whole-blood donations.[4]
  • $4.7 billion in donor compensation was paid by U.S. plasma centers in 2025; the estimate covers commercial plasma donation and excludes downstream plasma-derived-medicine revenue.[5]

Regional breakdown of the plasma donation industry

  • More than 150 plasma donation centers operated in Europe in the latest PPTA count; the figure covers centers operated by PPTA members.[6]
  • 1,247 commercial plasma donation centers operated in the United States at December 31, 2025, including four in Puerto Rico.[5]
  • Three dedicated source-plasma collection centers operated in the United Kingdom in 2024–25, located in Birmingham, Twickenham and Reading.[7]

06 Statistics

Operating Benchmarks

UK operations show scaling in both volume and participation, including 301,197 plasma-for-medicine units in 2024–25 and 6,279 regular donors recorded by NHS Blood and Transplant.

Operating metrics used in the plasma donation industry

  • 301,197 plasma-for-medicine units were collected in the United Kingdom in 2024–25, combining source and recovered plasma and rising 87.0% year over year.[7]
  • 6,279 regular plasma donors were recorded by NHS Blood and Transplant in the United Kingdom in 2024–25, up 31.1% from 4,790 in 2023–24.[7]
  • Regular United Kingdom plasma donors averaged 3.27 donations over 12 months in 2024–25, compared with 3.16 in the preceding year.[7]

07 Statistics

Delivery & Operations

Center counts underline network concentration, including 310 U.S. centers at year-end 2025 and nearly 330 plasma centers across the United States, Germany and Hungary in 2025.

Delivery capacity and installed base in the plasma donation industry

  • More than 1,000 IQPP-certified plasma donation centers operated in the United States; PPTA does not publish a newer exact national count on this page.[6]
  • Nearly 330 plasma centers operated across the United States, Germany and Hungary in 2025.[2]
  • 310 plasma centers operated in the United States at year-end 2025.[8]
  • More than 270 BioLife donation centers operated across the United States and Europe in FY2025.[9]

08 Statistics

Pricing

U.S. donor compensation varies by program and location, with BioLife advertising up to $725 in 2026 and CSL Plasma advertising up to $800 during a first-month window in 2026.

Fees and price levels in the plasma donation industry

  • Up to $725 during the first month was advertised by BioLife’s Jacksonville center for new donors in 2026; the amount is location-specific.[10]
  • Up to $100 per first donation was advertised by CSL Plasma in 2026; the amount varies by U.S. location.[2]
  • Up to $800 during the first month was advertised by CSL Plasma for new U.S. plasma donors in 2026; the amount varies by location.[2]

09 Statistics

Risk & Compliance

Operational rules constrain donor throughput and quarantine timing, including a 48-hour minimum interval and a 45 calendar day quarantine hold period under FDA’s October 2023 compliance policy.

Regulation and licensing in the plasma donation industry

  • 48 hours is the minimum interval between Source Plasma donations, and donors may donate no more than twice in seven days under 21 CFR 640.65(b)(8), applicable to U.S. plasma-collection establishments.[11]
  • 72 hours is the permitted period for clarifying incomplete donor responses after collection under FDA’s October 2023 compliance policy, versus the usual 24-hour requirement.[12]
  • 45 calendar days is the quarantine hold period FDA permits for Source Plasma under its October 2023 compliance policy, replacing the standard 60-day period when specified conditions are met.[12]

Client data and confidentiality in the plasma donation industry

  • 190 Octapharma Plasma donation centers in 35 U.S. states were identified in the April 2024 breach allegations as affected locations, establishing the geographic scale of a sector-specific client-data incident.[13]
  • 1,423 Iowa residents were potentially affected by Octapharma Plasma’s April 2024 data-security incident involving personal, financial and health-related information.[14]
  • 388 Maryland residents were potentially affected by BioLife Plasma Services’ February 2024 credential-stuffing breach, which involved donor scheduling and plasma-donation information.[15]

Incidents, safety and loss events in the plasma donation industry

  • In 2022 U.S. plasma-surveillance data, hematomas represented 51.1% and hypotension 42.2% of reported donor adverse events, according to Grifols’ reported IQPP categorization.[1]
  • First-time U.S. Source Plasma donors experienced 136.66 adverse events per 10,000 donations versus 12.37 for repeat donors in the same industry-wide plasmavigilance study.[16]
  • 15.85 adverse events occurred per 10,000 U.S. Source Plasma donations in the study period, based on 12.33 million donations from 1,076,469 donors across three PPTA member companies.[16]

10 Statistics

Sustainability

Reported emissions vary by scope and methodology in plasma-related operations, including Grifols reporting 106,289 tonnes of Scope 1 CO2e and 1,051,606 tonnes of Scope 3 CO2e for fiscal 2024.

Energy, emissions and disclosure in the plasma donation industry

  • 1,051,606 tonnes of CO₂e were reported as Scope 3 emissions by Grifols, including its plasma-collection and manufacturing operations, for fiscal year 2024; the FY2024 metrics were third-party assured.[8]
  • 26.14 MWh per tonne of plasma was reported as Octapharma’s 2024 emission-rate indicator for its plasma-related operations worldwide.[17]
  • 106,289 tonnes of CO₂e were reported as Scope 1 emissions by Grifols, including its plasma-collection and manufacturing operations, for fiscal year 2024; the metric was third-party assured.[8]

Key questions about the Plasma Donation Industry

What is the global market size for plasma donation and related plasma fractionation in 2026?
The global plasma fractionation market is estimated at $42.15B in 2026.
How fast is the market expected to grow from 2026 to 2031?
Mordor Intelligence forecasts growth from $38.88B in 2025 to $63.06B in 2031, an 8.4% CAGR from 2026 to 2031.
Which companies lead the plasma donation industry?
Grifols stands out for operating a large worldwide plasma collection network because it operates over 390 plasma donation centers through BioMat, while Eurofins Transplant Genomics focuses on plasma donation testing services since it provides infectious disease screening.
What automation or collection technology changes were reported recently?
Haemonetics reports nearly 100% of source-plasma collections worldwide used automated collection technology at dedicated facilities in fiscal 2026, and CSL reduced donation time from 90–120 minutes to 60–80 minutes after adding 200+ Rika plasmapheresis machines in 2025.
How is the industry structured across upstream collection and downstream products?
Plasma collection is the essential upstream input for immunoglobulins, albumin and coagulation products, with segmentation by collection type and downstream product.
What are key U.S. operational constraints for donor scheduling and plasma quarantine holds?
U.S. Source Plasma minimum interval is 48 hours and donors may donate no more than twice in seven days under 21 CFR 640.65(b)(8). FDA permits a 45 calendar day quarantine hold period for Source Plasma under its October 2023 compliance policy.
Reference

Cite This Report

This report is designed to be cited. We maintain stable URLs and versioned verification dates. Copy the format appropriate for your publication below.

APA
Aisha Okonkwo. (2026, February 13). Plasma Donation Industry Statistics. Gitnux. https://gitnux.org/plasma-donation-industry-statistics
MLA
Aisha Okonkwo. "Plasma Donation Industry Statistics." Gitnux, 13 Feb 2026, https://gitnux.org/plasma-donation-industry-statistics.
Chicago
Aisha Okonkwo. 2026. "Plasma Donation Industry Statistics." Gitnux. https://gitnux.org/plasma-donation-industry-statistics.